Strengthen Your Defenses Naturally with CBDa and CBGa

CBDA (cannabidiolic acid) and CBGA (cannabigerolic acid) are acidic cannabinoids naturally produced by the hemp plant. They’re closely related to CBD and CBG, but they have different chemical structures and research profiles.

Interest in these raw cannabinoids continues to grow as researchers investigate their interaction with different biological pathways, including serotonin receptors, TRP channels, and other cellular targets.

In this guide, we’ll explain what CBDA and CBGA are, how CBDA compares with CBGA, what research currently suggests about their potential effects, how heat changes these compounds, and what to look for when choosing a quality product.

What Are CBDA and CBGA?

CBDA and CBGA are acidic cannabinoids naturally found in raw, unheated hemp.

CBDA is the acidic precursor associated with CBD, while CBGA is an important precursor involved in the plant’s production of several other cannabinoids.

When exposed to heat, these acidic cannabinoids can undergo decarboxylation, changing their chemical structures. CBDA can convert to CBD, while CBGA can convert to CBG.

Neither CBDA nor CBGA is known for producing the intoxicating effects associated with THC.

What Is CBDA?

CBDA stands for cannabidiolic acid.

It is naturally present in raw hemp and cannabis plants before heat changes it into CBD through decarboxylation.

For years, CBD received most of the attention in hemp research. CBDA, however, has become increasingly interesting to researchers because it has its own molecular properties rather than simply being an inactive version of CBD.

Early research has investigated CBDA’s interaction with pathways involving:

• 5-HT1A serotonin receptors
• COX-2 signaling
• TRP channels
• inflammatory signaling
• gastrointestinal and nausea-related pathways

What Is CBGA?

CBGA stands for cannabigerolic acid.

CBGA is another naturally occurring acidic cannabinoid found in raw hemp.

It is sometimes described as a foundational or “mother” cannabinoid because the plant uses CBGA as a starting point in the biosynthesis of several other cannabinoids.

Through enzymatic processes in the plant, CBGA contributes to the formation of acidic cannabinoids that can later become familiar compounds such as CBD, CBG, and THC after further transformation and decarboxylation.

CBDA vs. CBGA: What’s the Difference?

Feature	CBDA	CBGA
Full Name	Cannabidiolic Acid	Cannabigerolic Acid
Found Naturally In	Raw Hemp	Raw Hemp
Related Cannabinoid	CBD	CBG
Acidic Cannabinoid	Yes	Yes
Intoxicating	Not known to be intoxicating	Not known to be intoxicating
Research Status	Emerging	Emerging
Plant Role	Associated with CBD biosynthesis	Important precursor in cannabinoid biosynthesis

CBDA vs. CBD: What’s the Difference?

CBDA and CBD are chemically related, but they aren’t identical.

CBDA is the acidic form found naturally in raw hemp. When heat is applied, CBDA can undergo decarboxylation and become CBD.

That means the way hemp is grown, extracted, processed, and heated can influence the cannabinoid profile of the final product.

If you’re specifically interested in acidic cannabinoids, look for products that clearly identify CBDA content rather than assuming a CBD product automatically contains significant amounts of CBDA.

CBGA vs. CBG: What’s the Difference?

CBGA and CBG are also closely related.

CBGA is the acidic form, while CBG is the corresponding neutral cannabinoid.

Heat can promote decarboxylation, converting CBGA into CBG.

Because processing can change the cannabinoid profile, consumers interested in CBGA should look beyond the product name and review the Certificate of Analysis (CoA) to see which cannabinoids are actually present.

What Are the Potential Benefits of CBDA?

Research into CBDA is still emerging, but several areas have attracted scientific interest.

1. Research Into Inflammatory Signaling

Laboratory research has investigated CBDA’s interaction with COX-2, an enzyme involved in pathways associated with prostaglandin production.

These findings have helped researchers identify CBDA as an interesting compound for further investigation.

2. Nausea-Related Research

Researchers have also studied CBDA’s interaction with the 5-HT1A serotonin receptor, a receptor involved in several neurological processes, including pathways associated with nausea.

Animal studies have reported interesting results, but more human research is needed before concluding how these findings translate to people.

3. Bioavailability Research

Another area attracting attention is how efficiently CBDA is absorbed.

Emerging pharmacokinetic research suggests that the body’s exposure to acidic cannabinoids can depend on factors such as:

• formulation
• dosage
• delivery method
• food intake
• lipid carriers
• individual metabolism

This is one reason formulation deserves attention when comparing cannabinoid products.

4. Cellular Signaling Research

Researchers are also studying CBDA’s interactions with different molecular pathways.

This includes research involving TRP channels and other signaling systems that help regulate cellular responses.

These findings are interesting, but most remain at the preclinical stage.

What Are the Potential Benefits of CBGA?

CBGA is receiving increasing scientific attention as researchers investigate its biological activity.

1. Research Into Cellular Signaling

CBGA interacts with several biological targets beyond the traditional cannabinoid receptors.

Researchers have investigated its relationship with pathways involving TRP channels, nuclear receptors, and other signaling systems.

2. Oxidative Stress Research

Preclinical research has explored whether CBGA may influence biological pathways associated with oxidative stress.

Again, these findings should be viewed as early scientific evidence, not proof of a specific health outcome in humans.

3. Cannabinoid Biosynthesis

CBGA is especially interesting because of its role within the hemp plant itself.

It acts as an important precursor in the biosynthesis of several acidic cannabinoids, making it useful for understanding how the plant produces its broader cannabinoid profile.

What Does the Research Say About CBDA and CBGA?

This is where context matters.

Not every cannabinoid study provides the same level of evidence.

Laboratory research

Cell-based studies can help researchers understand how a compound interacts with specific proteins, receptors, or pathways.

These experiments are useful for generating hypotheses, but they don’t demonstrate that the same effect occurs in humans.

Animal research

Animal studies can provide additional information about biological mechanisms and potential effects.

However, results from animals cannot automatically be applied to humans.

Human research

Human studies provide stronger evidence for understanding how a compound behaves in people.

For CBDA and CBGA, human research remains comparatively limited, although interest in cannabinoid pharmacokinetics and formulation continues to grow.

The bottom line

CBDA and CBGA are scientifically interesting compounds with growing research interest, but more high-quality human research is needed.

That distinction is important when evaluating online claims about cannabinoids.

What About the CBDA and CBGA Virus Research?

One study that generated considerable attention investigated CBDA and CBGA in relation to SARS-CoV-2.

The research reported that these compounds interacted with the viral spike protein and inhibited viral entry in laboratory models.

But there’s a crucial distinction:

A laboratory finding is not the same as demonstrating that a compound prevents or treats a viral infection in humans.

How Does Heat Affect CBDA and CBGA?

If you’re interested in acidic cannabinoids, processing is worth understanding.

Raw hemp naturally contains acidic cannabinoids such as CBDA and CBGA.

When heat is applied, a process called decarboxylation can remove a carboxyl group from these molecules.

In simple terms:

CBDA → CBD

CBGA → CBG

How to Choose a Quality CBDA or CBGA Product

If you’re shopping for a product containing acidic cannabinoids, don’t rely only on the front label.

A few things are worth checking.

1. Look for a current Certificate of Analysis

A batch-specific Certificate of Analysis (CoA) can help verify cannabinoid content and provide information about testing.

Ideally, the report should identify:

• CBDA
• CBGA
• CBD
• CBG
• THC
• other relevant cannabinoids

Depending on the product, you may also want to review testing for:

• heavy metals
• pesticides
• residual solvents
• microbial contaminants

2. Check the cannabinoid profile

If a product is marketed specifically for its acidic cannabinoid content, the CoA should provide evidence supporting that claim.

Don’t assume a product contains meaningful amounts of CBDA or CBGA simply because the words appear in its marketing.

3. Consider processing methods

If preserving acidic cannabinoids is important to you, look for products that explain how the extract is processed.

Low-heat or minimally processed approaches may be used when the goal is to retain acidic cannabinoids.

4. Look at storage recommendations

Heat, light, and prolonged storage can influence cannabinoid stability.

Follow the manufacturer’s storage instructions and keep products away from excessive heat and direct sunlight.

5. Choose transparency

A reputable hemp company should make it reasonably easy to understand:

• what’s in the product
• how much is present
• how it was tested
• where the testing came from
• how the product should be stored

Transparency is more valuable than exaggerated marketing claims.

Are CBDA and CBGA Intoxicating?

CBDA and CBGA are not known for producing the intoxicating effects associated with THC.

However, products containing multiple cannabinoids can have different compositions.

If a product is full-spectrum, check its current laboratory report for the cannabinoid profile and THC content.

Always consider the laws and product requirements that apply where you live.

Are CBDA and CBGA Safe?

Research into the safety of CBDA and CBGA is still developing.

Because human evidence is limited, consumers should be cautious about assuming that “natural” automatically means risk-free.

If you’re pregnant, nursing, have a medical condition, or take prescription or over-the-counter medications, speak with a qualified healthcare professional before using cannabinoid products.

This is particularly important because cannabinoids may interact with certain medications or metabolic pathways.

How Should CBDA and CBGA Products Be Stored?

Proper storage can help maintain product quality.

As a general approach:

• Keep products in a cool environment.
• Avoid prolonged exposure to heat.
• Protect products from direct sunlight.
• Keep containers tightly closed.
• Follow the manufacturer’s storage instructions.
• Check expiration or best-by information when provided.

FAQ’s

What are CBDA and CBGA?

CBDA and CBGA are acidic cannabinoids naturally produced by raw hemp. CBDA is associated with the CBD pathway, while CBGA is an important precursor in the plant’s cannabinoid biosynthesis.

What is the difference between CBDA and CBGA?

Both are acidic cannabinoids, but they are different molecules. CBDA is the acidic cannabinoid associated with CBD, while CBGA serves as an important precursor for multiple cannabinoid pathways.

Is CBDA the same as CBD?

No. CBDA and CBD are chemically related but distinct compounds. Heat can convert CBDA into CBD through decarboxylation.

Is CBGA the same as CBG?

No. CBGA is the acidic form associated with CBG. Heat can convert CBGA into CBG.

Do CBDA and CBGA get you high?

CBDA and CBGA are not known to produce the intoxicating effects associated with THC.

CBDA and CBGA: Key Takeaways

CBDA and CBGA are two naturally occurring acidic cannabinoids that deserve attention as research continues to develop.

Here’s what to remember:

• CBDA and CBGA occur naturally in raw hemp.
• CBDA is associated with the CBD pathway.
• CBGA is an important precursor in cannabinoid biosynthesis.
• Heat can convert CBDA to CBD and CBGA to CBG.
• Early research has identified several interesting biological pathways.
• Much of the current evidence remains preclinical.
• Human research is still developing.
• A Certificate of Analysis can help verify a product’s cannabinoid profile.
• Product formulation and processing can affect cannabinoid composition.
• Health claims should not be inferred from preliminary laboratory findings.

Important: This article is for educational purposes only and is not medical advice. Research on CBDA and CBGA is still developing, and much of the available evidence comes from laboratory and animal studies rather than large human clinical trials.

References and further reading

• Van Breemen RB et al. Cannabinoids block cellular entry of SARS-CoV-2. J Nat Prod 2022.

• Takeda S et al. CBDA is a selective COX-2 inhibitor. Bioorg Med Chem 2008.

• Bolognini D et al. CBDA prevents vomiting via 5-HT1A enhancement in animal models. Br J Pharmacol 2013.

• Li S et al. Cannabigerol review of mechanisms and therapeutic potential. 2024.

• Krzyżewska A et al. CBG mini-review on oxidative stress and signalling. 2025.

• Wang TC et al. Pharmacokinetics of carboxylated cannabinoids in humans. 2025. 

• Wakshlag JJ et al. Pharmacokinetics of CBD and CBDA in dogs. 2020.

• FDA statements and regulatory resources on cannabis-derived products.

• USDA, Congress and Brookings explainer on hemp definition and the 0.3 per cent delta-9 THC threshold.